Medical research

Macaque trials offer hope in pneumonia vaccine development

The global impact of the coronavirus pandemic has ignited a renewed focus on emerging and re-emerging infectious diseases. Researchers at Osaka Metropolitan University are making great strides in combating pneumococcal pneumonia, ...

Diseases, Conditions, Syndromes

Serious pneumococcal infections may increase the risk of heart attack

Patients with serious pneumococcal infections, including pneumonia and sepsis, are at a substantially increased risk of heart attack after the onset of infection according to a Vanderbilt study published in Clinical Infectious ...

Arthritis & Rheumatism

Rheumatologist recommends patients receive pneumococcal vaccine

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against ...

Vaccination

Q&A: Examining low vaccine uptake among at-risk Canadians

As the flu season begins and the COVID-19 pandemic continues, pneumococcal vaccination is more important than ever to prevent disease and death from pneumonia and other forms of pneumococcal disease.

Vaccination

New vaccines and old can curb drug resistance

Trials of new vaccine candidates must be accelerated and existing vaccine use stepped up to prevent life-threatening infections that can no longer be beaten by antimicrobial medicines, the World Health Organization (WHO) ...

Diseases, Conditions, Syndromes

Vaccine reduces likelihood of severe pneumonia

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

page 2 from 9